Last reviewed · How we verify
Efadermin (lithium succinate)
Efadermin (generic name: lithium succinate) is a lithium succinate drug. It is currently in unknown development.
Efadermin is thought to work by modulating lithium levels in the body, which can affect various cellular processes.
Efadermin, also known as lithium succinate, is a small molecule drug in the lithium succinate class. Its mechanism of action and target are unknown, and it has not been approved by the FDA for any indications. The commercial status of efadermin is unclear, and it is not known whether it is patented or available as a generic. Further research is needed to determine the safety and efficacy of this compound. As a result, key safety considerations and approved indications are currently unavailable.
At a glance
| Generic name | lithium succinate |
|---|---|
| Drug class | lithium succinate |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
In simple terms, efadermin is believed to help regulate the amount of lithium in the body, which can then influence how cells function. This can have a range of effects on the body, but the exact mechanisms are not yet fully understood.
Approved indications
Common side effects
Drug interactions
- lisinopril
- losartan
- meclofenamic acid
- mefenamic acid
- meloxicam
- methylclothiazide
- metolazone
- nabumetone
- naproxen
- oxaprozin
- perindopril
- phenylbutazone
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Efadermin CI brief — competitive landscape report
- Efadermin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Efadermin
What is Efadermin?
How does Efadermin work?
What is the generic name of Efadermin?
What drug class is Efadermin in?
What development phase is Efadermin in?
Related
- Drug class: All lithium succinate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing